Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis (Q73207706)
Jump to navigation
Jump to search
scientific article published on 01 April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis |
scientific article published on 01 April 2003 |
Statements
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis (English)
Rolf Rau
Piet van Riel
Leo van de Putte
Fritz Hasler
Michel Zaug
Johannes Kneer
Philippe van der Auwera
Randall M Stevens
Rheumatology Group 791